IOL CHEMICALS & PHARM. | IND. SWIFT | IOL CHEMICALS & PHARM./ IND. SWIFT |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 12.4 | 3.3 | 371.7% | View Chart |
P/BV | x | 1.4 | - | - | View Chart |
Dividend Yield | % | 1.1 | 0.0 | - |
IOL CHEMICALS & PHARM. IND. SWIFT |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
IND. SWIFT Mar-23 |
IOL CHEMICALS & PHARM./ IND. SWIFT |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 15 | 3,668.5% | |
Low | Rs | 272 | 7 | 4,187.7% | |
Sales per share (Unadj.) | Rs | 377.6 | 75.9 | 497.7% | |
Earnings per share (Unadj.) | Rs | 23.7 | 4.8 | 493.0% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 10.1 | 312.5% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | -130.1 | -197.4% | |
Shares outstanding (eoy) | m | 58.71 | 54.16 | 108.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.1 | 769.1% | |
Avg P/E ratio | x | 17.1 | 2.2 | 776.4% | |
P/CF ratio (eoy) | x | 12.8 | 1.0 | 1,224.9% | |
Price / Book Value ratio | x | 1.6 | -0.1 | -1,939.3% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 572 | 4,149.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 637 | 263.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 4,110 | 539.5% | |
Other income | Rs m | 256 | 119 | 216.0% | |
Total revenues | Rs m | 22,427 | 4,228 | 530.4% | |
Gross profit | Rs m | 2,257 | 1,026 | 219.9% | |
Depreciation | Rs m | 462 | 287 | 161.0% | |
Interest | Rs m | 165 | 598 | 27.6% | |
Profit before tax | Rs m | 1,887 | 260 | 724.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 0 | - | |
Profit after tax | Rs m | 1,391 | 260 | 534.4% | |
Gross profit margin | % | 10.2 | 25.0 | 40.8% | |
Effective tax rate | % | 26.2 | 0 | - | |
Net profit margin | % | 6.3 | 6.3 | 99.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 2,734 | 353.6% | |
Current liabilities | Rs m | 5,025 | 9,363 | 53.7% | |
Net working cap to sales | % | 20.9 | -161.3 | -13.0% | |
Current ratio | x | 1.9 | 0.3 | 658.8% | |
Inventory Days | Days | 43 | 115 | 37.6% | |
Debtors Days | Days | 8 | 929 | 0.9% | |
Net fixed assets | Rs m | 11,017 | 3,758 | 293.2% | |
Share capital | Rs m | 587 | 108 | 542.0% | |
"Free" reserves | Rs m | 14,490 | -7,155 | -202.5% | |
Net worth | Rs m | 15,077 | -7,047 | -214.0% | |
Long term debt | Rs m | 0 | 4,031 | 0.0% | |
Total assets | Rs m | 20,684 | 6,492 | 318.6% | |
Interest coverage | x | 12.5 | 1.4 | 867.5% | |
Debt to equity ratio | x | 0 | -0.6 | -0.0% | |
Sales to assets ratio | x | 1.1 | 0.6 | 169.3% | |
Return on assets | % | 7.5 | 13.2 | 56.9% | |
Return on equity | % | 9.2 | -3.7 | -249.8% | |
Return on capital | % | 13.6 | -28.4 | -47.8% | |
Exports to sales | % | 26.7 | 68.8 | 38.9% | |
Imports to sales | % | 0 | 5.3 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 2,827 | 209.8% | |
Imports (cif) | Rs m | NA | 217 | 0.0% | |
Fx inflow | Rs m | 5,930 | 2,947 | 201.2% | |
Fx outflow | Rs m | 6,052 | 313 | 1,930.9% | |
Net fx | Rs m | -122 | 2,634 | -4.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 730 | 167.4% | |
From Investments | Rs m | -1,200 | -293 | 408.9% | |
From Financial Activity | Rs m | -41 | -466 | 8.8% | |
Net Cashflow | Rs m | -18 | -29 | 64.4% |
Indian Promoters | % | 48.2 | 55.6 | 86.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 2.5 | 0.0 | - | |
FIIs | % | 2.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 44.4 | 116.6% | |
Shareholders | 134,235 | 14,219 | 944.1% | ||
Pledged promoter(s) holding | % | 0.0 | 42.8 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | IND. SWIFT | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.31% | 8.28% | 1.18% |
1-Month | -9.26% | -2.97% | -0.75% |
1-Year | 29.97% | 161.80% | 61.82% |
3-Year CAGR | -13.41% | 59.03% | 18.16% |
5-Year CAGR | 13.41% | 27.79% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the IND. SWIFT share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of IND. SWIFT the stake stands at 55.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of IND. SWIFT.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
IND. SWIFT paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of IND. SWIFT.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.